Electroencephalograph for Detection of Acute Ischemic Stroke
|ClinicalTrials.gov Identifier: NCT01737723|
Recruitment Status : Unknown
Verified November 2012 by Neurokeeper Technologies.
Recruitment status was: Recruiting
First Posted : November 29, 2012
Last Update Posted : November 29, 2012
|Condition or disease||Intervention/treatment|
|Stroke||Device: Neurokeeper stroke detector|
Inclusion criteria study population Age > 18 years old. Acute stroke symptoms onset within 120 hours of inclusion, and as proximate to event as possible.
Acute ischemic moderate or severe hemispheric stroke (assessed as 5 points or more by NIHSS) and including patients treated by t-PA
Exclusion criteria study population Primary intracranial hemorrhage on admission by CT. Significant movement disorder. Previous major hemispheric stroke. Local skull or skin affliction which prevents electrodes application. Any known condition which in the opinion of the investigator may interfere with the protocol implementation.
Inclusion criteria Control Population
Age > 18 years old.
Exclusion criteria Control Population Primary intracranial hemorrhage on admission by CT. Significant movement disorder. Previous major hemispheric stroke. Local skull or skin affliction which prevents electrodes application. Migraine Any known condition which in the opinion of the investigator may interfere with the protocol implementation.
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Observational Model:||Case Control|
|Official Title:||Collecting Data for an Electroencephalograph Based Algorithm for Detection of Onset and Deterioration of Acute Ischemic Stroke by Comparison to NIHSS|
|Study Start Date :||August 2011|
Device: Neurokeeper stroke detector
Monitoring stroke patients
- Detection of strokeEEG base algorithm system to detect and monitor changes in cerebral electrophysiological parameters as compared to clinical evaluation as assessed by NIHSS score.
- Correlation to severity of strokeCorrelations between EEG + ERP changes and clinical status as assessed by NIHSS score.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01737723
|Contact: Shay Bar Haim, Mscemail@example.com|
|Rambam Medical Center||Recruiting|
|Contact: Moshe Herskovitz, MD 97248542605 firstname.lastname@example.org|
|Principal Investigator: Gregory Telman, MD|